Vimarsana
Biggest News Aggregation in the World

Page 4 - Offering Shares News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Offering Shares. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Offering Shares Today - Breaking & Trending Today

Aelis Farma, a biopharmaceutical company developing a new generation of drugs for brain diseases, announces the success of its initial public offering and raises approximately €25 million on Euronext Paris - Vimarsana News

Aelis Farma, a biopharmaceutical company developing a new generation of drugs for brain diseases, announces the success of its initial public offering and raises approximately €25 million on Euronext Paris

Capital increase of approximately €25 million, i.e. 100% of the initial objective, despite high market volatility Size of the transaction which may be increased to approximately €25.55 million

Aelis Farma, a Biopharmaceutical Company Developing a New Generation of Drugs for Brain Diseases, Launches Its Initial Public Offering on the Regulated Market of Euronext Paris - Vimarsana News

Aelis Farma, a Biopharmaceutical Company Developing a New Generation of Drugs for Brain Diseases, Launches Its Initial Public Offering on the Regulated Market of Euronext Paris

02.02.2022 - Regulatory News: Not to be distributed, directly or indirectly, in the United States of America, Canada, Australia, Japan or South Africa. Aelis Farma, a clinical-stage biopharmaceutical company specializing in the development of treatments for ...

Aelis Farma, a Biopharmaceutical Company Developing a New Generation of Drugs for Brain Diseases, Launches Its Initial Public Offering on the Regulated Market of Euronext Paris - Vimarsana News

Aelis Farma, a Biopharmaceutical Company Developing a New Generation of Drugs for Brain Diseases, Launches Its Initial Public Offering on the Regulated Market of Euronext Paris

Capital increase of €25 million, which may be increased to a maximum of approximately €33 million in the event the Extension Clause and the Over-Allotment Option are fully exercised Irrevocable

EnerSpar Corp.: EnerSpar and Israeli-Based Nurexone Announce Definitive Agreement - Vimarsana News

EnerSpar Corp.: EnerSpar and Israeli-Based Nurexone Announce Definitive Agreement

Calgary, Alberta--(Newsfile Corp. - January 18, 2022) - EnerSpar Corp. (TSXV: ENER) (FSE: 5E0) ("EnerSpar" or the "Company") is pleased to announce that they have entered into an arm's length securities

Investegate |Southern Energy Corp Announcements | Southern Energy Corp: CLOSING OF EQUITY FINANCING AND OPERATIONAL UPDATE - Vimarsana News

Investegate |Southern Energy Corp Announcements | Southern Energy Corp: CLOSING OF EQUITY FINANCING AND OPERATIONAL UPDATE

Investegate announcements from Southern Energy Corp, CLOSING OF EQUITY FINANCING AND OPERATIONAL UPDATE